|
Market Cap (4-Jun) $23,964,560 (896th) |
Close (30-Jun) $0.043 |
Volume (30-Jun) 1,415,719 |
Shortsold (5-Nov) 11,657 (0.00%) (566th) |
|
52w High $0.135 |
52w Low $0.043 |
P/E - |
EPS -0.02 |
NOX released this announcement to the ASX on 27 July 2022, 9:30. The announcement is marked as price sensitive, and is 9 page(s) in length and 464.3kb in size.
You can view all announcements from NOX and see how they appear on a price chart on the announcements page.
At the date of this announcement, NOX was 0.213% short sold according to ASIC data. It was ranked the 425th most shorted stock on the ASX. It remains ranked 566th as of the latest reported data (05 November 2025).
| Other Recent Announcements from NOX | |
|---|---|
| Change of Director's Interest Notice - FB | 29 June 2023, 12:08 |
| Change of Director's Interest Notice - FB | 19 June 2023, 19:08 |
| Change of Director's Interest Notice - BP | 19 June 2023, 19:08 |
| June 2022 Quarterly Activities Report and Appendix 4C | 27 July 2022, 9:30 |
| Mayo Clinic and Washington Uni Join Noxopharm Sarcoma Trial | 5 July 2022, 8:42 |
| $1.45M Grant to Hudson Institute for Noxopharm Collaboration | 22 June 2022, 9:33 |
| HIMR Collaboration Secures mRNA Vic Acceleration Fund Grant | 14 June 2022, 11:11 |
You must be logged in to post a reply.
Noxopharm 